PBM PE Ratio & Valuation,Is PBM Overvalued

PBM Relative Valuation

PBM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, PBM is overvalued; if below, it's undervalued.

Historical Valuation

Psyence Biomedical Ltd (PBM) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Psyence Biomedical Ltd (PBM) is between -- to -- according to relative valuation methord.

Relative Value

Fair Zone

-----

Current Price：1.48

Fair

0.00

EV/EBITDA

Psyence Biomedical Ltd. (PBM) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.

0.00

EV/EBIT

Psyence Biomedical Ltd. (PBM) has a current EV/EBIT of 0.00. The 5-year average EV/EBIT is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBIT of 0.00 falls within the Strongly Undervalued range.

0.00

Psyence Biomedical Ltd. (PBM) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.

0.00

P/OCF

Psyence Biomedical Ltd. (PBM) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.

0.00

P/FCF

Psyence Biomedical Ltd. (PBM) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.

Psyence Biomedical Ltd (PBM) has a current Price-to-Book (P/B) ratio of 0.23. Compared to its 3-year average P/B ratio of -26.24 , the current P/B ratio is approximately -100.88% higher. Relative to its 5-year average P/B ratio of -21.71, the current P/B ratio is about -101.07% higher. Psyence Biomedical Ltd (PBM) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -85.43%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -70.72% , the current FCF yield is about -100.00% lower.

0.23

P/B

Median3y

-26.24

Median5y

-21.71

-143.73

FCF Yield

Median3y

-85.43

Median5y

-70.72

Competitors Valuation Multiple

The average P/S ratio for PBM's competitors is 0.00, providing a benchmark for relative valuation. Psyence Biomedical Ltd Corp (PBM) exhibits a P/S ratio of 0.00, which is NaN% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of PBM increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of PBM in the past 1 year is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is Psyence Biomedical Ltd (PBM) currently overvalued or undervalued?

What is Psyence Biomedical Ltd (PBM) fair value?

PBM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Psyence Biomedical Ltd (PBM) is between to according to relative valuation methord.

How does PBM's valuation metrics compare to the industry average?

What is the current P/B ratio for Psyence Biomedical Ltd (PBM) as of Dec 16 2025?

As of Dec 16 2025, Psyence Biomedical Ltd (PBM) has a P/B ratio of 0.23. This indicates that the market values PBM at 0.23 times its book value.

What is the current FCF Yield for Psyence Biomedical Ltd (PBM) as of Dec 16 2025?

As of Dec 16 2025, Psyence Biomedical Ltd (PBM) has a FCF Yield of 0.00%. This means that for every dollar of Psyence Biomedical Ltd’s market capitalization, the company generates 0.00 cents in free cash flow.

What is the current Forward P/E ratio for Psyence Biomedical Ltd (PBM) as of Dec 16 2025?

As of Dec 16 2025, Psyence Biomedical Ltd (PBM) has a Forward P/E ratio of 0.00. This means the market is willing to pay $0.00 for every dollar of Psyence Biomedical Ltd’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for Psyence Biomedical Ltd (PBM) as of Dec 16 2025?

As of Dec 16 2025, Psyence Biomedical Ltd (PBM) has a Forward P/S ratio of 0.00. This means the market is valuing PBM at $0.00 for every dollar of expected revenue over the next 12 months.

PBM Valuation

PBM Valuation

PBM Relative Valuation

Historical Valuation

Competitors Valuation Multiple

Performance Decomposition

People Also Watch

Frequently Asked Questions

Is Psyence Biomedical Ltd (PBM) currently overvalued or undervalued?

What is Psyence Biomedical Ltd (PBM) fair value?

How does PBM's valuation metrics compare to the industry average?

What is the current P/B ratio for Psyence Biomedical Ltd (PBM) as of Dec 16 2025?

What is the current FCF Yield for Psyence Biomedical Ltd (PBM) as of Dec 16 2025?

What is the current Forward P/E ratio for Psyence Biomedical Ltd (PBM) as of Dec 16 2025?

What is the current Forward P/S ratio for Psyence Biomedical Ltd (PBM) as of Dec 16 2025?